BioSpace News Archive

Deals

INVO Bioscience Announces Uplisting to OTCQB Market

INVO Bioscience, Inc. announced that its stock has commenced trading on the OTCQB Market (“OTCQB”) after successfully uplisting from the OTC Pink Market.

June 29, 2018
·
3 min read
Business

Jean-Marie Dru Welcomes the Return of Andy Hayley and Dick Dunford and Their Vision for TBWA\WorldHealth London

Jean-Marie Dru, Chairman, TBWA\Worldwide, Sharon Callahan, CEO TBWA\WorldHealth, and Robin Shapiro, Global President, TBWA\WorldHealth, today unveiled a new vision for TBWA\WorldHealth London.

June 29, 2018
·
5 min read
Business

Mark Farrah Associates Reported Improved Health Insurance Segment Profitability

Mark Farrah Associates (MFA), examined trends in membership, claims incurred PMPM (per member per month), adjusted premium PMPM and MLR (Medical Loss Ratio) for the Individual and Small Group comprehensive segment leaders.

June 29, 2018
·
2 min read
Business

R&D Chief Shook Retires from Pilot Chemical

40-year career included work developing industry-leading products

June 29, 2018
·
2 min read
Business

GeneNews Announces Election of Directors Conducted at the Company’s Annual and Special Meeting of Shareholders Held on June 28, 2018

GeneNews Limited announced that all of the nominee directors listed in the Company’s management information circular dated May 30, 2018

June 29, 2018
·
2 min read
Business

SeniorWell Partners with PracticeEHR

SeniorWell announced its partnership with PracticeEHR.

June 29, 2018
·
1 min read
Business

Northwell Health, Feinstein Institute executives chosen to advise Sanguistat

Health care leaders to support emerging medical device company in developing solutions to control acute and chronic bleeding

June 29, 2018
·
4 min read
Business

Epidemiologists tout largest workforce size since 2001; Identify remaining gaps in disease surveillance capacity

Ebola, Addiction, Mental Health Among Key Public Health Priorities Facing Insufficient Surveillance Capacity

June 29, 2018
·
3 min read
Business

Retractable Technologies, Inc. Declares Dividends to Series I and II Class B Convertible Preferred Stock Shareholders

Retractable Technologies, Inc. (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series I Class B and Series II Class B Convertible Preferred Stock in the amounts of $12,312.50 and $42,800.00, respectively.

June 29, 2018
·
2 min read
FDA

FDA approves novel device for treating breathing difficulty from severe emphysema

The U.S. Food and Drug Administration (FDA) today approved a new device, the Zephyr Endobronchial Valve (Zephyr Valve), intended to treat breathing difficulty associated with severe emphysema.

June 29, 2018
·
4 min read